Related Experiment Video
Updated: Jun 17, 2026
05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Metabolic acuity score: effect on major complications after bariatric surgery
Robin P Blackstone1, Melisa C Cortés
1Scottsdale Bariatric Center, Scottsdale, Arizona 85258, USA. blackstonemd@scottsdalebariatric.com
Summary
Implementing a Metabolic Acuity Score (MAS) significantly reduced major complications, readmissions, and reoperations in bariatric surgery patients. This score aids in preoperative assessment for better patient outcomes.
Area of Science:
- Bariatric Surgery
- Surgical Outcomes
- Patient Acuity Assessment
Background:
- Obesity comorbidities increase bariatric surgery complications and costs.
- Existing risk factors for mortality are known but rare.
- A Metabolic Acuity Score (MAS) can improve preoperative assessment.
Purpose of the Study:
- To evaluate the impact of a Metabolic Acuity Score (MAS) on major complications after bariatric surgery.
- To determine if MAS implementation reduces readmissions and reoperations.
- To enhance preoperative patient assessment and management.
Main Methods:
- Prospective evaluation of 2416 bariatric surgery patients (Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding).
- Implementation of MAS (groups 1-4) in 1072 patients based on various health factors.
- Comparison of outcomes (complications, readmissions, reoperations) before and after MAS implementation.
Main Results:
- Significant decrease in 30-day readmission rates (8.5% to 1.7%) for Roux-en-Y gastric bypass.
- Lower postoperative infection rates (3.5% to 0.7%) after MAS implementation.
- MAS significantly reduced internal hernias, infections, deep vein thrombosis, readmissions, and reoperations.
Conclusions:
- MAS implementation and aggressive perioperative management lowered major complication rates.
- MAS effectively decreased readmissions and reoperations post-bariatric surgery.
- Patient acuity assessment via MAS optimizes surgical outcomes.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...